The medical recommendations for adult LCH have been published in Orphanet Journal of Rare Diseases.

More ...
An­nu­al in­ter­na­tio­nal con­fe­rence of sci­en­tists, pa­tho­lo­gists and cli­ni­ci­ans discussing histiocytoses and their backgrounds. More ...
An International Community of Professionals Dedicated to Research and Treatment More ...
PubMed comprises more than 20 million citations for biomedical literature from MEDLINE, life science journals, and online books. More ...

European Union Clinical Trials Register of the European Medicines Agency

More ...

European Clinical Trials Database of the European Medicines Agency

More ...
Rare diseases in EU
Why do rare diseases need specific EU support? More ...
Euro Histio Net has received funding from the European Union, in the framework of the Public Health Programme. More ...
» Expert Histio Net » For Professionals » Guidelines » LCH adult » Organ involvement » Endocrinologic dysfunction  · 

Endocrinologic dysfunction

Author(s): Euro Histio Net Work Group for LCH Guidelines for adults (see introduction page), Created: 2012/07/26, last update: 2013/08/18

LCH exhibits a predilection for the hypothalamo-pituitary (HP) region leading to permanent posterior and/or anterior pituitary hormonal deficiencies in a subset of patients.

Diabetes insipidus (DI)

Diabetes Insipidus (DI) is the most common disease-related consequence that can predate the diagnosis or develop anytime during the course of the disease [Kaltsas et al 2000; Prosch et al 2004]. DI is found in up to 30% of patients [Arico et al 2003], but may reach to 40% in patients with multisystem disease or 94% in the presence of other pituitary deficiencies [Kaltsas et al 2000; Makras et al 2007]. Polyuria and polydipsia, and/or structural abnormalities of the HP region dictate investigations to confirm DI.

Anterior pituitary hormonal deficiencies

Anterior pituitary dysfunction (APD) is found in up to 20% of patients, almost always with DI [Kaltsas et al 2000; Amato et al 2006]. Although APD is not invariably associated with abnormal HP imaging it is almost always encountered in patients with MS LCH who have DI and HP pathology on MR imaging [Makras et al 2006]. Growth hormone deficiency (GHD) is the most frequent disease-related APD found in up to 50% of patients with DI [Makras et al 2007]. In adults there are no specific GHD-related symptoms that can suggest the diagnosis [Donadieu et al 2004c].

Gonadotropin deficiency is the second most common deficiency, presenting with menstrual disturbances in women and decreased libido in men [Makras et al 2007]. ACTH deficiency may be partial or complete and present either with non-specific symptoms or as acute adrenal insufficiency following stressful events. TSH deficiency is almost always associated with panhypopituitarism and may present with subtle symptoms or obvious signs of hypothyroidism. Moderately elevated prolactin levels attributed to pituitary stalk infiltration can cause galactorrhoea in females and gonadotropin deficiency in all patients. Established endocrine deficiencies almost never recover over time, although apparent HP abnormal imaging may often regress either in response to treatment or as a result of the “natural course” of the disease [Makras et al 2006].

Hypothalamic involvement

Hypothalamic involvement is less frequent than pituitary involvement and leads to not only pituitary dysfunction, but neuropsychiatric and behavioral disorders, disturbances of thermo-regulation and sleeping pattern, and autonomic and metabolic abnormalities. The most frequent consequence is severe obesity due to increased appetite. Hypothalamic-related adipsia may seriously complicate the management of diabetes insipidus.

Metabolic abnormalities

One study involving 14 adult patients and 42 controls has shown that adults with LCH are at high risk of developing abnormalities of carbohydrate metabolism (diabetes mellitus, impaired glucose tolerance) and lipid metabolism leading to increased insulin resistance even in the absence of obesity [Alexandraki et al 2008].

Bone metabolism

Adults with LCH may present with a lower than expected bone mineral density at any age especially during periods of active disease [Makras et al 2012].

Other endocrine tissue involvement

The thyroid gland may occasionally be involved in the disease process while fine needle aspiration or even histological specimens may be mistaken with thyroid carcinoma. Unlike the lower genital tract, ovaries are quite rarely involved, mostly in the context of disseminated disease. Adrenal infiltration has been described in autopsy series although without any obvious clinical findings. Pancreatic involvement is also extremely rare, although there are reports of glucose metabolism abnormalities secondary to pancreatic and/or hepatic infiltration and dysfunction.

Investigation of hormonal deficiencies

A plasma osmolality in the range of 280- 295mOsmol/Kg in combination with an urine to plasma osmolality ratio > 2:1 exclude apparent DI, whereas a water deprivation test is usually required to reveal cases of partial DI. An early morning serum cortisol level ≥ 500 nmol/l (18 μg/dl) virtually excludes ACTH deficiency, whereas a cortisol level < 100 nmol/l (3.6 μg/dl) is suggestive of ACTH deficiency. For intermediate serum cortisol values an insulin tolerance test (ITT), if not contra-indicated, can access the adequacy of hypothalamic (HP)-adrenal axis as well as GH reserve. Although an insulin-like growth factor I (IGF-I) level below the age-adjusted normal range may be suggestive of growth hormone deficiency (GHD), it is not as reliable as the GH response to the ITT or other dynamic tests. Low basal gonadal steroids along with low gonadotropin levels in the presence of a relevant clinical setting are suggestive of hypogonadotropin hypogonadism. Occasionally in young females with menstrual disturbances and low oestradiol levels, failure of gonadotropin levels to rise in response to clomiphene stimulation is required to confirm the diagnosis. Finally, lack of TSH elevation in the presence of a low serum T4 level is indicative of TSH deficiency in the absence of the non-thyroidal illness syndrome.


Evaluation of TSH, free T4 and morning urine osmolality is recommended in all patients, further procedures (water deprivation test, plasma osmolality, serum cortisol, insulin like growth factor I, gonadal steroids and gonadotropin serum levels) to detect partial diabetes insipidus or anterior pituitary deficiencies should be performed when clinical symptoms are present (Grade D2 *).

* Grades of recommendation see here.


[Kaltsas et al 2000] Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM, Grossman AB: Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000, 85: 1370-6. [PMID: 10770168]

[Prosch et al 2004] Prosch H, Grois N, Prayer D, Waldhauser F, Steiner M, Minkov M, Gadner H: Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatric blood & cancer 2004, 43: 594 [PMID: 15382278]

[Arico et al 2003] Aricò M, Girschikofsky M, Généreau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C: Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. European journal of cancer (Oxford, England : 1990) 2003, 39: 2341 [PMID: 14556926]

[Makras et al 2007] Makras P, Alexandraki KI, Chrousos GP, Grossman AB, Kaltsas GA: Endocrine manifestations in Langerhans cell histiocytosis. Trends in endocrinology and metabolism: TEM 2007, 18: 252 [PMID: 17600725]

[Amato et al 2006] Amato MC, Elias LL, Elias J, Santos AC, Bellucci AD, Moreira AC, De Castro M: Endocrine disorders in pediatric - onset Langerhans Cell Histiocytosis. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2006, 38: 746 [PMID: 17111302]

[Makras et al 2006] Makras P, Samara C, Antoniou M, Zetos A, Papadogias D, Nikolakopoulou Z, Andreakos E, Toloumis G, Kontogeorgos G, Piaditis G, Kaltsas GA: Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 2006, 48: 37 [PMID: 16292545]

[Donadieu et al 2004c] Donadieu J, Rolon MA, Pion I, Thomas C, Doz F, Barkaoui M, Robert A, Deville A, Mazingue F, David M, Brauner R, Cabrol S, Garel C, Polak M, French LCH Study Group: Incidence of growth hormone deficiency in pediatric-onset Langerhans cell histiocytosis: efficacy and safety of growth hormone treatment. The Journal of clinical endocrinology and metabolism 2004, 89: 604 [PMID: 14764769]

[Alexandraki et al 2008] Alexandraki KI, Makras P, Protogerou AD, Dimitriou K, Stathopoulou A, Papadogias DS, Voidonikola P, Piaditis G, Pittas A, Papamichael CM, Grossman AB, Kaltsas G: Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities. QJM : monthly journal of the Association of Physicians 2008, 101: 31 [PMID: 18160417]

[Makras et al 2012] Makras P, Terpos E, Kanakis G, Papatheodorou A, Anastasilakis AD, Kokkoris P, Kaltsas GA: Reduced bone mineral density in adult patients with Langerhans cell histiocytosis. Pediatric blood & cancer 2012, 58: 819 [PMID: 21548013]